InVision Medical Technology
AI Diagnosis of Heart Disease
InVision Medical Technology operates in healthcare based in San Francisco, CA, USA.
Profile
At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.
InVision Medical Technology is positioned in healthcare, a segment that rewards a clear, focused offering.
Its base of operations is San Francisco, CA, USA.
The company is listed at the Summer 2022 stage of development.
The company reports a headcount in the 2 range.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 2 |
| Stage | Summer 2022 |
Website: invisionmedtech.com
Browse related
Create a free account